miR-181a-5p is downregulated in hepatocellular carcinoma and suppresses motility, invasion and branching-morphogenesis by directly targeting c-Met
- 1 August 2014
- journal article
- research article
- Published by Elsevier in Biochemical and Biophysical Research Communications
- Vol. 450 (4) , 1304-1312
Abstract
No abstract availableKeywords
Funding Information
- Turkish Scientific and Technological Research Council (111S265)
- Dokuz Eylul University Research Foundation (2012.KB.SAG.006)
This publication has 20 references indexed in Scilit:
- Cell-Autonomous and Non–Cell-Autonomous Mechanisms of HGF/MET–Driven Resistance to Targeted Therapies: From Basic Research to a Clinical PerspectiveCancer Discovery, 2013
- Cooperative interaction of MUC1 with the HGF/c-Met pathway during hepatocarcinogenesisMolecular Cancer, 2012
- Emerging roles of microRNA in the intracellular signaling networks of hepatocellular carcinomaJournal of Gastroenterology and Hepatology, 2011
- miR-34a inhibits migration and invasion by down-regulation of c-Met expression in human hepatocellular carcinoma cellsCancer Letters, 2009
- MicroRNAs: Target Recognition and Regulatory FunctionsCell, 2009
- Most mammalian mRNAs are conserved targets of microRNAsGenome Research, 2008
- Identification of metastasis-related microRNAs in hepatocellular carcinomaHepatology, 2008
- Hepatocellular carcinoma pathogenesis: from genes to environmentNature Reviews Cancer, 2006
- Met-regulated expression signature defines a subset of human hepatocellular carcinomas with poor prognosis and aggressive phenotypeJournal of Clinical Investigation, 2006
- MicroRNA expression profiles classify human cancersNature, 2005